Review/Discussion
NEW!
Sipahi OR.
Economics of antibiotic resistance. Expert Rev Anti Infect Ther
2008;6(4):523-39.
AVAILABLE FOR CME CREDIT!
Methicillin-Resistant Staphylococcus aureus: An Evolving Clinical
Challenge. Clinical Infectious Disease 2008;46(Suppl 5):
S339-S398. View the
CME Information and the
CME Questions.
Hirsch MS, Gunthard HF, Schapiro JM, Brun-Vezinet F, Clotet B, Hammer
SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen
DM, Richman DD.
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008
recommendations of an International AIDS Society - USA Panel.
Clinical Infectious Diseases 2008;47:266-285.
Clements A, Halton
K, Graves N, Pettitt A, Morton A, Looke D, Whitby M.
Overcrowding and understaffing in modern health-care systems: key
determinants in meticillin-resistant Staphylococcus aureus
transmission. Lancet Infect Dis. 2008;8:427-34.
Santos RP, Mayo TW, Siegel JD.
Healthcare Epidemiology: Active Surveillance Cultures and Contact
Precautions for Control of Multidrug-Resistant Organisms: Ethical
Considerations. Clinical Infectious Diseases 2008;47:110-116.
Davies J.
Resistance redux. Infectious diseases, antibiotic resistance and the
future of mankind. EMBO reports 2008; 9(S1):S18-S21.
John JF, Harvin AM.
History and evolution of antibiotic resistance in coagulase-negative
staphylococci: Susceptibility profiles of new anti-staphylococcal
agents. Ther Clin Risk Manag. 2007;3(6):1143-52.
Lewis K.
Multidrug tolerance of biofilms and persister cells. Curr Top
Microbiol Immunol 2008;322:107-31.
Anderson GG and O'Toole GA.
Innate and induced resistance mechanisms of bacterial biofilms.
Curr Top Microbiol Immunol 2008;322:85-105.
Tong SYC, McDonald MI, Holt DC, Currie BJ.
Global
Implications of the Emergence of Community-Associated
Methicillin-Resistant Staphylococcus aureus in Indigenous
Populations. Clinical Infectious Diseases 2008;
46(12):1871-1878.
Karchmer AW and Bayer AS.
Introduction: Methicillin-Resistant Staphylococcus aureus: An
Evolving Clinical Challenge. Clinical Infectious Diseases
2008;46(S5):S342-3.
Boucher HW and Corey GR.
Epidemiology of Methicillin-Resistant Staphylococcus aureus.
Clinical Infectious Diseases 2008;46(S5):S344-9.
Gordon RJ and Lowy FD.
Pathogenesis of Methicillin-Resistant Staphylococcus aureus
Infection. Clinical Infectious Diseases 2008;46(S5):S350-9.
Sakoulas G and Moellering RC Jr.
Increasing Antibiotic Resistance among Methicillin-Resistant
Staphylococcus aureus Strains. Clinical Infectious Diseases
2008;46(S5):S360-7.
Stryjewski ME and Chambers HF.
Skin and Soft-Tissue Infections Caused by Community-Acquired
Methicillin-Resistant Staphylococcus aureus.
Clinical Infectious Diseases 2008;46(S5):S368-77.
Rubinstein E, Kollef MH, and Nathwani D.
Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus.
Clinical Infectious Diseases 2008;46(S5):S378-85.
Cosgrove SE and Fowler VG Jr.
Management of Methicillin-Resistant Staphylococcus aureus
Bacteremia. Clinical Infectious Diseases 2008;46(S5):S386-93.
Chastre J.
Evolving problems with resistant pathogens. Clin Microbiol
Infect 2008;14(Suppl 3):3-14.
Maragakis LL, Perl TM.
Acinetobacter baumannii: epidemiology, antimicrobial
resistance, and treatment options. Clin Infect Dis
2008;46:1254-63
Siegel RE.
Emerging gram-negative antibiotic resistance: daunting challenges,
declining sensitivities, and dire consequences. Respir Care
2008; 53(4):471-9.
Rice LB.
Federal Funding for the Study of Antimicrobial Resistance in
Nosocomial Pathogens: No ESKAPE.
The Journal of Infectious Diseases 2008;
197(8): 1079-1081.
Friedman CR
and Whitney CG.
It's Time for a Change in Practice: Reducing Antibiotic Use Can Alter
Antibiotic Resistance.
The Journal of Infectious Diseases 2008;
197(8): 1082-1083.
Peters NK,
Dixon DM, Holland SM, and Fauci AS.
The Research Agenda of the National Institute of Allergy and
Infectious Diseases for Antimicrobial Resistance.
The Journal of Infectious Diseases 2008;
197(8): 1087-1093.
Boyce JM.
Community-associated Methicillin-Resistant Staphylococcus aureus as a
cause of health care-associated infection. Clinical Infectious
Diseases 2008;46:795-798.
Uckay I, Sax H, Harbarth S, Bernard L, Pittet D.
Multi-resistant infections in repatriated patients after natural
disasters: lessons learned from the 2004 tsunami for hospital
infection control. Journal of Hospital Infection
2008;68:1-8.
Griffin FA.
5 Million Lives Campaign. Reducing methicillin-resistant
Staphylococcus aureus (MRSA) infections. Joint
Commission Journal on Quality and Patient Safety 2007;33:726-31.
Waller S, Jim Beattie T.
Does antimicrobial prophylaxis affect recurrent urinary tract
infections and bacterial resistance in children? Nature
Clinical Practice Urology 2008 Feb 19 [Epub ahead of print].
Bellissimo-Rodrigues F.
Antimicrobial drug use and antibiotic-resistant bacteria.
Emerg Infect Dis. 2008 Jan;14(1):187-8.
Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC.
Vancomycin-resistant Staphylococcus aureus in the United States,
2002-2006. Clin Infect Dis. 2008 Mar 1;46(5):668-74.
Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA.
Growing problem of multidrug-resistant enteric pathogens in Africa.
Emerging Infectious Diseases 2007;13(11):1640-6.
Gorwitz RJ.
A review of community-associated Methicillin-resistant Staphylococcus
aureus skin and soft tissue infections. Pediatric Infectious
Disease Journal 2008;27:1-7.
Kanafani ZA, Perfect JR.
Resistance to antifungal agents: Mechanisms and clinical impact.
Clinical Infectious Diseases 2008;46:120-128.
Gorwitz RJ.
A review of community-associated methicillin-resistant
Staphylococcus aureus skin and soft tissue infections.
Pediatr Infect Dis J 2008;27:1-7.
Spellberg B, Guidos R, Gilbert D, Bradley
J, Boucher HW, Scheld WM, Bartlett JG, Edwards Jr. J.
The epidemic of antibiotic-resistant infections: A call to action for
the medical community from the Infectious Diseases Society of America.
Clinical Infectious Diseases 2008;46:155-164.
Bush-Knapp ME, Brinsley-Rainisch KJ, Lawton-Ciccarone RM, Sinkowitz-Cochran
RL, Dressler DD, Budnitz T, Williams MV.
Spreading the word, not the infection: Reaching hospitalists about the
prevention of antimicrobial resistance. Am J Infect Control
2007;35:656-661.
Klein E, Smith DL, Laxminarayan R.
Hospitalizations and deaths caused by methicillin-resistant
Staphylococcus aureus, United States, 1999–2005. Emerg Infect
Dis [serial on the Internet]. 2007 Dec.
Moellering RC, Jr., Graybill JR, McGowan
JE, Jr., Corey L. Supplement:
Antimicrobial resistance prevention initiative--an update: Proceedings
of an expert panel on resistance. American Journal of Infection
Control 2007;35:21A-S26.
Gross PA, Patel B.
Reducing antibiotic overuse: a call for a national performance measure
for not treating asymptomatic bacteriuria. Clin Infect Dis.
2007 Nov 15;45(10):1335-7.
Humphreys H.
Understanding why methicillin-resistant staphylococcus aureus control
measures are successful in different countries. Infect
Control Hosp Epidemiol 2007;28:1418-1419.
DANMAP. Use of
antimicrobial agents and occurrence of antimicrobial resistance in
bacteria from food animals, foods and humans in Denmark. 2006.
Danish Veterinary and Food Administration; Danish Medicines Agency;
National Veterinary Institute and National Food Institute, Technical
University of Denmark.
New York City Department of Health and
Mental Hygiene.
Surveillance for vancomycin resistance in Staphylococcus aureus. 2007 Alert # 31.
Foley SL, Lynne AM.
Food animal-associated Salmonella challenges: Pathogenicity and
antimicrobial resistance. J Anim Sci. 2007 Sep 18; [Epub ahead of
print].
Verma C, Seebah S, Low SM, Zhou L, Liu SP,
Li, J, Beuerman RW.
Defensins: Antimicrobial peptides for therapeutic development.
Biotechnol J. 2007 Sep 20; [Epub ahead of print].
Shardell M, Harris AD, El-Kamary SS,
Furuno JP, Miller RR, Perencevich EN.
Statistical analysis and application of quasi experiments to
antimicrobial resistance intervention studies. Clin Infect Dis.
2007 Oct 1; 45(7): 901-907.
Neofytos D, Kuhn B, Shen S, Zhu XH,
Jungkind D, Flomenberg P.
Emergence of staphylococcal cassette chromosome mec type IV
methicillin-resistant Staphylococcus aureus as a cause of
ventilator-associated pneumonia. Infect Control Hosp Epidemiol.
2007 Oct; 28(10): 1206-1209.
Conterno LO, Shymanski J, Ramotar K, Toye
B, van Walraven C, Coyle D, Roth R.
Real-time polymerase chain reaction detection of methicillin-resistant
Staphylococcus aureus: Impact on nosocomial transmission and
costs. Infect Control Hosp Epidemiol. 2007 Oct; 28(10):1134-1141.
Clemmitt M.
Fighting
Superbugs. The CQ Researcher. 2007 Aug 24; 17: 673-696.
(Reprinted with permission from CQ Press. View other articles in this
publication at:
CQ Researcher.)
Ghanem G, Hachem R, Jian Y, Chemaly RF,
Raad I.
Outcomes for and risk factors associated with vancomycin-resistant
Enterococcus faecalis and vancomycin-resistant Enterococcus
faecium bacterium in cancer patients. Infect Control Hosp
Epidemiol. 2007 Sept; 28(9): 1054-1059.
Hoste EAJ, Vandijck DM, Vanholder RC, De
Waele JJ, Lameire NH, Claus S, et al.
Health implications of antimicrobial resistance for patients with
acute kidney injury and bloodstream infection. Infect Control Hosp
Epidemiol. 2007 Sept; 28(9): 1107-1110.
Plantenga MS, Strausbaugh LJ, Infectious
Diseases Society of America Emerging Infections Network.
Use of decolonization to prevent staphylococcal infections in various
healthcare settings: Results of an Emerging Infections Network survey.
Infect Control Hosp Epidemiol. 2007 Sept; 28(9): 1111-1113.
Kader AA, Kumar A, Kamath KA.
Fecal carriage of extended-spectrum beta-lactamase-producing
Escherichia coli and Klebsiella pneumoniae in patients and
asymptomatic healthy individuals. Infect Control Hosp Epidemiol.
2007 Sept; 28(9): 1114-1116.
Wenzel RP, Bearman G, Edmond MB.
Community-acquired methicillin-resistant Staphylococcus aureus
(MRSA): New issues for infection control. Intern J Antim Agents.
2007 Sept; 30(3): 210-212.
Perlin DS.
Resistance to
echinocandin-class antifungal drugs. Drug Resis Updates. 2007; 10:
121-130.
September 1st Supplement of Clinical Infectious Diseases is
devoted to antimicrobial resistance.
September 15th Supplement of Clinical Infectious Diseases is
devoted to antimicrobial resistance.
Li J, Nation RL, Owen RJ, Wong S, Spelman
D, Franklin C.
Antibiograms of multidrug-resistant clinical Acinetobacter
baumannii: Promising therapeutic options for treatment of
infection and colistin-resistant strains. Clin Infect Dis. 2007
Sept 1; 45(5): 594-598.
Boucher HW & Sakoulas G.
Perspectives on daptomycin resistance, with emphasis on resistance in
Staphylococcus aureus. Clin Infect Dis. 2007 Sept 1; 45(5):
601-608.
Elixhauser A & Steiner C.
Infections with
methicillin-resistant Staphylococcus aureus (MRSA) in U.S.
hospitals, 1993-2005. Healthcare Cost and Utilization Project (HCUP),
Agency for Healthcare Research and Quality. 2007 Jul; Statistical
Brief #35.
Moellering RC Jr, Graybill JR, McGowan JE Jr, Corey L.
Antimicrobial resistance prevention initiative--an update: Proceedings
of an expert panel on resistance. Am J Med. 2007 Jul; 120(7):
S4-25.
Hotz RL.
Evolution at work: Watching bacteria grow drug resistant. Science
Journal of the The Wall Street Journal. 2007 June 8; B1.
Deresinski S.
Vancomycin: Does it still have a role as an antistaphylococcal agent?
Expert Rev Anti Infect Ther. 2007 Jun; 5(3):393-401.
Gillespie EE, Boer FJ, Stuart RL, Buist MD, Wilson JM.
A sustained reduction in the transmission of methicillin resistant
Staphylococcus aureus in an intensive care unit. Crit Care
Resusc. 2007 Jun; 9(2):161-5.
Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ,
Noreddin AM, Karlowsky JA.
Comparative review of the carbapenems. Drugs. 2007;
67(7):1027-52.
Goldstein FW.
Combating resistance in a challenging, changing environment. Clin
Mircoiol Infect. 2007 Jun; 13 Suppl 2:2-6.
Rossolini GM.
Redesigning beta-lactams to combat resistance: Summary and
conclusions. Clin Microbiol Infect. 2001 Jun; 13 Suppl 2:30-3.
Handsfield HH.
Methicillin-resistant Staphylococcus aureus infections in sex
partners: What is a sexually transmitted disease? (Letter to the
editor.) Clin Infect Dis. 2007 June 15; 44(12): 1664.
Cook HA, Furuya EY, Larson E, Vasquez G, Lowy FD.
Reply to Handsfield. Clin Infect Dis. 2007 June 15; 44(12): 1664.
Mohr JF, Murray BE.
Point: Vancomycin is not obsolete for treatment of infection caused by
methicillin-resistant Staphylococcus aureus. Clin Infect
Dis. 2007 June 15; 44(12): 1536-42.
Deresinkski S.
Counterpoint: Vancomycin and Staphylococcus aureus - an
antibiotic enters obsolescence. Clin Infect Dis. 2007 June 15;
44(12): 1543-8.
Haar CH, Cobelens FGJ, Kalisvaart NA, van der Have JJ, van Gerven PJHJ,
van Soolingen D.
Tuberculosis drug resistance and HIV infection, the Netherlands.
Emerg Infect Dis [serial on the Internet]. 2007 May.
Available from
http://www.cdc.gov/EID/content/13/5/776.htm.
Poirel L, Villa L, Bertini A, Pitout JD, Nordmann P, Carattoli A.
Expanded-spectrum β-lactamase and plasmid-mediated quinolone
Resistance. Emerg Infect Dis [serial on the Internet]. 2007 May. Available from
http://www.cdc.gov/EID/content/13/5/803.htm.
Mwangi MM, Shang WW, Zhou Y, Sieradzki K, de Lencastre H, Richardson
P, Bruce D, Rubin E, Myers E, Siggia ED, Tomasz A.
Tracking the in vivo evolution of multidrug resistance in
Staphylococcus aureus by whole-genome sequencing. Proceed Nat
Acad Sci. 2007 May; 104(22):9451-9456.
Cookson B.
Hypervirulent strains of Clostridium difficile. Postgrad Med J.
2007 May; 83(979):291-5.
Arias DC.
Tuberculosis rates level off, but drug resistance a concern: More
research, funding called for. The Nation's Health (Medscape).
2007; 37(4).
Wright GD, Sutherland AD.
New strategies for combating multidrug-resistant bacteria. Trends
Mol Med. 2007 May 8; [epub ahead of print].
Delgado M, Neto I, Correia JHD, Pomba
Constanca.
Antimicrobial resistance and evaluation of susceptibility testing
among pathogenic enterococci isolated from dogs and cats. Int J
Antimicrob Agents. 2007 May 15 [epub ahead of print].
Kawasaki K, China K, Nishijima M.
Release of lipopolysaccharide deacylase PagL from latency compensates
from lack of lipopolysaccharide aminoarabinose modification-dependent
resistance in antimicrobial peptide polymyxin B in Salmonella
enterica. J Bacteriol. 2007 May 4; [Epub ahead of print].
Bubacz MR.
Community-acquired methicillin-resistant Staphylococcus aureus:
An ever-emerging epidemic. AAOHN J. 2007 May; 55(5):193-4.
Veerman EC, Valentijn-Benz M, Nazmi K, Ruissen AL, Walgreen-Weterings
E, van Marle J, Doust AB, van T Hof W, Bolscher JG, Nieuw Amerongen
AV.
Energy depletion protects Candida albicans against
antimicrobial peptides by rigidifying its cell membrane. J Biol
Chem. 2007 May 7 [Epub ahead of print].
Hsu YM, Shieh HK, Chen WH, Sun TY, Shiang JH.
Antimicrobial susceptibility, plasmid profiles, and haemocin
activities of Avibacterium paragallinarum strains. Vet
Microbiol. 2007 Apr 19; [Epub ahead of print].
Toleman MA, Bennett PM, Bennett DMC, Ronald N. Jones RN, Walsh TR.
Global emergence of trimethoprim/sulfamethoxazole resistance in
Stenotrophomonas maltophilia mediated by acquisition of sul
genes. Emerg Infect Dis [serial on the Internet]. 2007 Apr.
Available from http://www.cdc.gov/EID/content/13/4/559.htm.
Saye DE.
Recurring and antimicrobial-resistant infections: Considering the
potential role of biofilms in clinical practice. Ostomy Wound
Manage. 2007 Apr; 53(4):46-62.
Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, Courvalin P, et al.
Global distribution of Panton-Valentine leukocidin–positive
methicillin-resistant Staphylococcus aureus, 2006. Emerg
Infect Dis [serial on the Internet]. 2007 Apr.
Available from
http://www.cdc.gov/EID/content/13/4/594.htm.
Falagas ME, Bliziotis IA, Michalopoulos A, Sermaides G, Papaioannou VE,
Nikita D, Choulis N.
Effect of a policy for restriction of selected classes of antibiotics
on antimicrobial drug cost and resistance. J Chemother 2007 Apr;
19(2): 178-84.
Diekema DJ, Edmond MB.
Look before you leap: Active surveillance for multidrug-resistant
organisms. Clin Infect Dis. 2007 Apr 15; 44(8): 1101-7.
Robert Wood Johnson Foundation.
Incentives essential to ease antibiotic resistance crisis. 2007
Mar.
Gorwitz RJ.
Editorial Commentary: The role of ancillary antimicrobial therapy for
treatment of uncomplicated skin infections in the era of
community-acquired methicillin-resistant Staphylococcus aureus.
Clin Infect Dis. 2007 Mar 15; 44:785-787.
Letter to the Editor.
The FDA and the evidence on an antibiotic. The Washington Post. 11
Mar 2007.
Editorial.
Resistant bugs. The Washington Post. 11 Mar 2007.
Falagas ME, Bliziotis IA, Fragoulis KN.
Oral rifampin for eradication of Staphylococcus aureus carriage
from healthy and sick populations: A systematic review of the evidence
from comparative trials. Am J Infect Control. 2007 Mar; 35(2)
106-14.
Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, et
al.
Legislative mandates for use of active surveillance cultures to screen
for methicillin-resistant Staphylococcus aureus and
vancomycin-resistant enterococci: Position statement from the Joint
SHEA and APIC Task Force. Am J Infect Control. 2007 Mar; 35(2)
73-85.
Zell BL, Goldmann DA.
Healthcare-associated infection and antimicrobial resistance: Moving
beyond description to prevention. Infect Control Hosp Epidemiol.
2007 Mar; 28(3): 261-4.
Rhoten, D.
Interdisciplinary research: Trend or transition. The Social
Science Research Council.
Weiss, R.
FDA rules override warnings about drug: Cattle antibiotic moves
forward despite fears of human risk. The Washington Post. 4
Mar 2007.
Mejicano GC, Wright M.
Web resources for antimicrobial resistance. Clin Infect Dis. 2007
Mar 15; 44:886-887.
Kim S, Hu J, Gautom R, Kim J, Lee B, Boyle DS.
CTX-M extended-spectrum β-lactamase, Washington State. Emerg
Infect Dis [serial on the Internet]. 2007 Mar.
Available from http://www.cdc.gov/EID/content/13/3/513.htm
Drudy D, Kyne L, O'Mahony, R, Fanning S.
gyrA mutations in fluoroquinolone-resistant Clostridium
difficile PCR-027. Emerg Infect Dis [serial on the Internet].
2007 Mar.
Available from http://www.cdc.gov/EID/content/13/3/504.htm
Kulwichit W, Chatsuwan T, Unhasuta C, Pulsrikarn C, Bangtrakulnonth A,
Chongthaleong A.
Drug-resistant nontyphoidal Salmonella bacteremia, Thailand.
Emerg Infect Dis [serial on the Internet]. 2007 Mar.
Available from http://www.cdc.gov/EID/content/13/3/501.htm
Reeves D.
The 2005 Garrod Lecture: The changing access of patients to
antibiotics - for better or worse? J Antimicrob Chemother. 2007
Feb 8; [Epub ahead of print].
Tega L, Raieta K, Ottaviani D, Russo GL, Blanco G, Carraturo A.
Catheter-related
bacteremia and multidrug-resistant Acinetobacter lwoffii
[letter]. Emerg Infect Dis [serial on the Internet]. 2007 Feb.
Available from
http://www.cdc.gov/EID/content/13/2/355.htm.
Bizzarro MJ, Gallagher PG.
Antibiotic-resistant organisms in the neonatal intensive care unit.
Semin Perinatol. 2007 Feb; 31:26-32.
Falagas ME, Karveli EA.
The changing global epidemiology of Acinetobacter baumannii
infections: A development with major public health
implications. Clin Microbiol Infect. 2007 Feb;13(2):117-9.
Johnson, AP.
Drug Evaluation: OPT-80, a narrow-spectrum antibiotic. Curr
Opin Investig Drugs. 2007 Feb; 8(2):168-73.
Su Z, Honek JF.
Emerging bacterial enzyme targets. Curr Opin Investig Drugs. 2007
Feb; 8(2): 140-9.
Witte W, Strommenger B, Stanek C, Cuny C.
Methicillin-resistant Staphylococcus aureus ST398 in humans and
animals, central Europe. Emerg Infect Dis [serial on the
Internet]. Feb 2007. Available from
http://www.cdc.gov/EID/content/13/2/255.htm.
Vila J, Marti S, Sanchez-Cespedes J.
Porins, efflux pumps and multidrug resistance in Acinobacter
baumannii. J Antimicrob Chemother. 2007 Feb 26; [Epub
ahead of print].
Klugman KP.
Clinical impact of antibiotic resistance in respiratory tract
infections. Intern Jr Antimicr Agents. 2007; 29 (Suppl): S6-S10.
Talbot TR.
Two Studies Feed the Debate on Active Surveillance for Methicillin-Resistant
Staphylococcus aureus and Vancomycin-Resistant Enterococci Carriage:
To Screen or Not to Screen?. Journal of Infectious
Diseases 2007;195:314-317.
Benton C.
Hand hygiene - meeting the JCAHO safety goal: Can compliance with CDC
hand hygiene guidelines be improved by a surveillance and educational
program? Plast Surg Nurs. 2007 Jan-Mar; 27(1):40-4.
Ocana V, Silva C, Nader-Macias ME.
Antibiotic susceptibility of potentially probiotic vaginal
lactobacilli. Infect Dis Obstet Gynecol. 2006 Sep; 14(3): 181-82.
Pletz MWR, Fugit RV, McGee L, Glasheen JJ, Keller DL, Welte T, Klugman
KP.
Fluoroquinolone-resistant Streptococcus pneumoniae
[letter]. Emerg Infect Dis
[serial online]. 2006
Sep.
Available
from
http://www.cdc.gov/ncidod/EID/vol12no09/05-1400.htm
|
Download the reprint of this article
Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E.
Emergence and resurgence of meticillin-resistant Staphylococcus aureus
as a public-health threat. Lancet 2006;368:874-885.
Heuer OE, Hammerum AM, Collignon P, Wegener HC.
Human health hazard from antimicrobial-resistant enterococci in
animals and food. Clin Infect Dis 2006;43:911-916.
Gkrania-Klotsas E, Hershow RC.
Colonization or infection with multidrug-resistant Acinetobacter
baumannii may be an independent risk factor for increased mortality.
Clin Infect Dis 2006;43:1224.
October 2006 issue of
Infection Control and Hospital Epidemiology devoted to MRSA.
Weber DJ, Rutala WA.
Use of germicides in the home and the healthcare setting: is there a
relationship between germicide use and antibiotic resistance?
Infect Control Hosp Epidemiol 2006;27:1107-1119.
Yagupsky P.
Selection of antibiotic-resistant pathogens in the
community. Pediatr Infect Dis J 2006;25:974-976.
Heuer OE, Hammerum AM, Collignon P, Wegener HC.
Human health hazard from antimicrobial-resistant enterococci in
animals and food. Clin Infect Dis 2006;43:911-916.
Falagas M.E. and
Kopterides P. Risk
factors for the isolation of multi-drug-resistant Acinetobacter
baumannii and Pseudomonas aeruginosa: a systematic review of the
literature Journal of Hospital Infection, Volume 64, Issue
1, September 2006, Pages 7-15.
Henderson DK.
Managing methicillin-resistant
staphylococci: A paradigm for preventing nosocomial transmission of
resistant organisms American Journal of Infection Control,
Volume 34, Issue 5, Supplement 1, June 2006, Pages S46-S54.
Grundmann H,
Aires-de-Sousa M, Boyce J, Tiemersma E.
Emergence
and resurgence of meticillin-resistant Staphylococcus aureus as a
public-health threat.
The Lancet, Volume 368, Issue 9538, 2 September 2006-8 September 2006,
Pages 874-885.
Paterson DL.
Serious infections in the intensive care unit: Pseudomonas
aeruginosa and Acinetobacter baumannii. Clin Infect
Dis 2006;43:S41-S42.
Bonomo RA, Szabo
D.
Mechanisms of multidrug resistance in Acinetobacter species and
Pseudomonas aeruginosa. Clin Infect Dis 2006;43:S49-S56.
Harris AD,
McGregor JC, Furuno JP.
What infection control interventions should be undertaken to control
multidrug-resistant gram-negative bacteria? Clin Infect Dis
2006;43:S57-S61.
Kollef MH.
Is antibiotic cycling the answer to preventing the emergence of
bacterial resistance in the intensive care unit? Clin Infect Dis
2006;43:S82-S88.
Rice LB.
Challenges in identifying new antimicrobial agents effective for
treatment infections with Acinetobacter baumannii and
Pseudomonas aeruginosa. Clin Infect Dis 2006;43:S100-S105.
Harbarth S, Emonet
S.
Navigating the World Wide Web in search of resources on antimicrobial
resistance. Clin Infect Dis 2006;43:72-78.
Tenover FC.
Mechanisms of antimicrobial resistance in
bacteria American Journal of Infection Control, Volume 34,
Issue 5, Supplement 1, June 2006, Pages S3-S10.
Fishman N.
Antimicrobial stewardship. Am J Med 2006;119(6 Suppl 1):S53-S61;
discussion S62-S70.
Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JGM, et al.
Self-medication with
Antimicrobial Drugs in
Europe.
Emerg Infect Dis [serial online]. 2006 Mar.
Available
from
http://www.cdc.gov/ncidod/eid/vol12no03/05-0992.htm |
Download the reprint of this article
Metlay JP, Powers
JH, Dudley MN, Christiansen K, Finch RG; on behalf of the Second
Colloquium of the International Forum on Antibiotic Resistance.
Antimicrobial Drug Resistance, Regulation and Research. Emerg Infect
Dis [serial online]. 2006 Feb.
Available
from
http://www.cdc.gov/ncidod/eid/vol12no02/05-0078.htm |
Download the reprint of this article
Davey P, Brown E,
Fenelon L, Finch R, Gould I, Holmes A, et al. Systematic review of
antimicrobial drug prescribing in hospitals. Emerg Infect Dis [serial
online]. 2006 Feb.
Available
from
http://www.cdc.gov/ncidod/eid/vol12no02/05-0145.htm |
Download the reprint of this article
Closing the Quality Gap: A Critical Analysis of Quality Improvement
Strategies: Volume 4 - Antibiotic Prescribing Behavior
(Publication No. 04(06)-0051-4), January 2006.
Alanis AJ.
(2005).
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Archives of Medical Research 36:697-705.
Larson EL, Saiman
L, Haas J, Neumann A, Lowy FD, Fatato B, Bakken S, and members of the
Executive Committee and Expert Liaisons. (2005).
Perspectives on antimicrobial resistance: Establishing an
interdisciplinary research approach. American Journal of
Infection Control 33:410-418.
Courvalin P.
(2005).
Antimicrobial Drug Resistance: "Prediction is Very Difficult,
Especially about the Future." Emerg Infect Dis [serial on the
Internet].
Gaynes R, Edwards
JR, and the National Nosocomial Infections Surveillance System.
(2005).
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli.
Clinical Infectious Diseases 41:848-854.
Gaynes R, Edwards
JR, and the National Nosocomial Infections Surveillance System.
(2005). Overview of Nosocomial Infections Caused by Gram-Negative
Bacilli. Clinical Infectious Diseases 41:848-854. PS
|
HTML |
PDF (155.8k)
Weber JT,
Courvalin P. An emptying quiver: antimicrobial drugs and resistance.
Emerg Infect Dis [serial online]. 2005 Jun.
Available
from
http://www.cdc.gov/ncidod/EID/vol11no06/05-0471.htm |
Download the reprint of this article
Harbarth S, Samore
MA. Antimicrobial resistance determinants and future control. Emerg
Infect Dis [serial online]. 2005 Jun.
Available
from
http://www.cdc.gov/ncidod/EID/vol11no06/05-0167.htm |
Download the reprint of this article
Cummings KC,
Rosenberg J, Vugia DJ. Beliefs about appropriate antibacterial
therapy, California. Emerg Infect Dis [serial online]. 2005 Jul.
Available
from
http://www.cdc.gov/ncidod/EID/vol11no07/05-0112.htm |
Download the reprint of this article
McCarthy J. (2004).
Tackling the Challenges of Interdisciplinary Bioscience.
Molecular Cell Biology 5:933-937.
Levy S.
Antibacterial household products: cause for concern. Presentation from
the 2000 Emerging Infectious Diseases Conference in Atlanta, GA.
Available
from
http://www.cdc.gov/ncidod/EID/vol7no3_supp/levy.htm
Hawley LA, Fridkin
SK, Whitney CG. Drug-resistant Streptococcus pneumoniae and
methicillin-resistant Staphylococcus aureus surveillance. Emerg
Infect Dis [serial online] 2003 Oct.
Available
from
http://www.cdc.gov/ncidod/EID/vol9no10/03-0454.htm |
Download the reprint of this article
Back to
Top
Research: Epidemiologic/Descriptive
NEW!
Datta R, Huang SS.
Risk of Infection and Death due to Methicillin-Resistant
Staphylococcus aureus in Long-Term Carriers.
Clinical Infectious Diseases 2008;47(2):176-181.
Laupland KB, Ross T, Gregson DB.
Staphylococcus aureus Bloodstream Infections: Risk Factors, Outcomes,
and the Influence of Methicillin Resistance in Calgary, Canada,
2000-2006. J Infect Dis 2008 Jun 3; [Epub ahead of print]
Al-Harthi AA, Al-Fifi SH.
Antibiotic resistance pattern and empirical therapy for urinary tract
infections in children. Saudi Med J.
2008;29(6):854-8.
Franke MF, Appleton SC, Bayona J, et al.
Risk Factors and Mortality Associated with Default from
Multidrug-Resistant Tuberculosis Treatment.
Clinical Infectious Diseases 2008; 46(12): 1844-1851.
Dagan R,
Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T, Lipsitch M, and
Greenberg D.
Seasonality of Antibiotic Resistant
Streptococcus pneumoniae That Causes Acute Otitis Media: A Clue
for an Antibiotic-Restriction Policy? The
Journal of Infectious Diseases 2008; 197(8): 1094-1102.
Popovich KJ,
Weinstein RA, Hota B.
Are community-associated Methicillin-Resistant Staphylococcus aureus
(MRSA) strains replacing traditional nosocomial MRSA strains?
Clinical Infectious Diseases 2008;46:787-794.
Wang JL, Chen SY,
Wang JT, Wu GHM, Chiang WC, et al.
Comparison of Both Clinical Features and Mortality Risk Associated
with Bacteremia due to Community-Acquired Methicillin-Resistant
Staphylococcus aureus and Methicillin-Susceptible S. aureus.
Clinical Infectious Diseases 2008;46:799-806.
Sievert, DM,
Rudrik, JT, Patel, JB, McDonald, LC, Wilkins, MJ, Hageman, JC.
Vancomycin-Resistant Staphylococcus aureus in the United
States, 2002–2006. Clinical Infectious
Diseases 2008;46:668–674.
Zhanel GG, Decroby M, Laing N, Weshnoweski B, Vashisht R, Tailor F,
Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagace-Wiens P,
Walkty A, McCracken M, Mulvey MR, Johnson J, The Canadian
Antimicrobial Resistance Alliance (CARA), Hoban DJ.
Antimicrobial resistant pathogens in intensive care units in Canada:
Results of the Canadian National Intensive Care Unit (CAN-ICU) Study,
2005/2006. Antimicrobial Agents and Chemotherapy 2008 Feb 19
[Epub ahead of print].
Libert M, Elkholti M, Massaut J, Karmali R, Mascart G, Cherifi S.
Risk factors for meticillin resistance and outcome of
Staphylococcus aureus bloodstream infection in a Belgian
university hospital. Journal of Hospital Infection
2008;68:17-24.
Stone ND, Lewis DR, Lowery HK, Darrow LA, Kroll CM, Gaynes RP,
Jernigan JA, McGowan JE Jr., Tenover FC, and Richards CL Jr.
Importance of bacterial burden among Methicillin-resistant
Staphylococcus aureus carriers in a long-term care facility.
Infection Control and Hospital Epidemiology February
2008;29(2):143-148.
Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein, RA. Risk
of hand or glove contamination after contact with patients colonized
with Vancomycin-resistant
Enterococcus
or the colonized patients’ environment.
Infection Control and Hospital Epidemiology February
2008;29(2):149-154.
Tolomeo P, Wheeler M, Metlay JP, Armstrong K, Fishman NO, Bilker WB,
Lautenbach E.
Patient attitudes regarding participation in studies of antimicrobial
resistance. Infection Control and Hospital Epidemiology February
2008;29(2):155-159.
Soriano A, Marco F, Martinez JA, Pisos E,
Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J.
Influence of vancomycin minimum inhibitory concentration on the
treatment of methicillin-resistant Staphylococcus aureus
bacteremia. Clinical Infectious Diseases 2008;46:193-200.
Scott E, Vanick K.
A survey of hand hygiene practices on a residential college campus.
Am J Infect Control 2007;35;694-696.
Tousman S, Arnold D, Helland W, Roth R,
Heshelman N, Castaneda O, Fischer E, O'Neil K, Bileto S.
Evaluation of a hand washing program for 2nd-graders. J Sch
Nurs 2007;23:342-348.
Jarvis WR, Schlosser J, Chinn RY, Tweeten
S, Jackson M.
National prevalence of methicillin-resistant Staphylococcus aureus
in inpatients at US health care facilities, 2006. Am J
Infect Control 2007;35;631-637.
Gasink LB, Zaoutis TE, Bilker WB,
Lautenbach E.
The categorization of prior antibiotic use: Impact on the
identification of risk factors for drug resistance in case
control studies. Am J Infect Control 2007;35:638-642.
Bennett NJ, Bull AL, Dunt DR, Gurrin LC,
Spelman DW, Russo PL, Richards MJ.
MRSA infections in smaller hospitals, Victoria, Australia.
Am J Infect Control 2007;35:697699.
Pillay M, Sturm AW.
Evolution
of the Extensively Drug-Resistant
F15/LAM4/KZN Strain of Mycobacterium tuberculosis in KwaZulu-Natal,
South Africa.
Clinical
Infectious Diseases
2007;45:1409–1414.
Iseman MD.
Extensively Drug‐Resistant
Mycobacterium tuberculosis: Charles Darwin Would Understand.
Clinical Infectious Diseases 2007;45:1415–1416.
Coenen S, Ferech M, Haaijer-Ruskamp FM,
Butler CC, Vander Stichele RH, Verheij TJ, Monnet DL, Little P,
Goossens H; ESAC Project Group. European
Surveillance of Antimicrobial Consumption (ESAC): quality indicators
for outpatient antibiotic use in Europe. Qual Saf Health Care
2007;16:440-445.
Ofner-Agostini
M, Varia M, Johnston L, Green K, Simor A, Amihod B, Bryce E, Henderson
E, Stegenga J, Bergeron F, Gravel D.
Infection control and antimicrobial restriction practices for
antimicrobial-resistant organisms in Canadian tertiary care hospitals.
American Journal of Infection Control 2007;35:563-568.
van Loo, IHM,
Diederen BMW, Savelkoul PHM, Woudenberg JHC, Roosendaal R, van Belkum A, et al.
Methicillin-resistant Staphylococcus aureus in meat products, the
Netherlands. Emerg Infect Dis [serial on the Internet]. 2007 Nov.
Available from
http://www.cdc.gov/EID/content/13/11/1753.htm
Ménard D,
Randrianarivo-Solofoniaina AE, Ahmed BS, Jahevitra M, Andriantsoanirina LV,
Rasolofomanana JR, et al.
Drug-resistant malaria parasites introduced into
Madagascar from Comoros Islands. Emerg Infect Dis [serial on the
Internet]. 2007 Nov. Available from
http://www.cdc.gov/EID/content/13/11/1759.htm
Karon AE, Archer
JR, Sotir MJ, Monson TA, Kazmierczak JJ.
Human multidrug-resistant Salmonella Newport infections, Wisconsin, 2003–2005. Emerg Infect Dis [serial on the
Internet]. 2007 Nov. Available from
http://www.cdc.gov/EID/content/13/11/1777.htm
Hammerum AM,
Heuer OE, Emborg H-D, Bagger-Skjøt L, Jensen V-F, Rogues AM, et al.
Danish
integrated antimicrobial resistance monitoring and research program. Emerg
Infect Dis [serial on the Internet]. 2007 Nov. Available
from http://www.cdc.gov/EID/content/13/11/1632.htm
Okeke IN,
Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA.
Growing problem of
multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis [serial on
the Internet]. 2007 Nov. Available from
http://www.cdc.gov/EID/content/13/11/1640.htm
Cohen AL, Shuler
C, McAllister S, Fosheim GE, Brown MG, Abercrombie D, et al.
Methamphetamine
use and methicillin-resistant Staphylococcus aureus skin infections. Emerg Infect Dis [serial on the Internet]. 2007 Nov. Available
from http://www.cdc.gov/EID/content/13/11/1707.htm
Whichard JM, Gay
K, Stevenson JE, Joyce KJ, Cooper KL, Omondi M, et al.
Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum
cephalosporins. Emerg Infect Dis [serial on the Internet]. 2007 Nov. Available from
http://www.cdc.gov/EID/content/13/11/1681.htm
Nimmo GR, Pearson JC, Collignon PJ, Christiansen KJ, Coombs GW, Bell
JM, McLaws ML; Australian Group for Antimicrobial
Resistance.
Prevalence of MRSA among Staphylococcus aureus isolated from hospital
inpatients, 2005: report from the Australian Group for Antimicrobial
Resistance. Commun Dis Intell. 2007 Sep;31(3):288-96.
Pogue JM, Paterson DL, Pasculle AM,
Potoski BA.
Determination of Risk Factors Associated With Isolation of
Linezolid-Resistant Strains of Vancomycin-Resistant Enterococcus.
Infect Control Hosp Epidemiol 2007;28:1382-1388.
Rogues AM, Cumartin C, Amadeo B, Venier
AG, Marty N, Parneix P, Gachie JP.
Relationship Between Rates of Antimicrobial Consumption and the
Incidence of Antimicrobial Resistance in Staphylococcus aureus and
Pseudomonas aeruginosa Isolates From 47 French Hospitals.
Infect Control Hosp Epidemiol 2007;28:1389-1395.
Guerra CM, Pereira CAP, Neto ARN, Cardo
DM, Correa L.
Physicians' perceptions, beliefs, attitudes, and knowledge concerning
antimicrobial resistance in a Brazilian teaching hospital.
Infect Control Hosp Epidemiol 2007;28:1411-1414.
Planta MB.
The role of poverty in antimicrobial resistance. J Am Board
Fam Med. 2007 Nov-Dec;20:533-9.
Niyogi SK.
Increasing antimicrobial resistance-an emerging problem in the
treatment of shigellosis. Clin Microbiol Infect.
2007;13:1141-1143.
Projan SJ, Bradford PA.
Late stage antibacterial drugs in the clinical pipeline.
Curr Opin Microbiol 2007 Oct 18; [Epub ahead of print].
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al.
Invasive
methicillin-resistant Staphylococcus aureus infections in the
United States. JAMA. 2007 Oct; 298(15):1763-1771.
Accompanying
JAMA editorial by Elizabeth Bancroft and
NY Times article by Kevin Sack.
Vickers AA, Chopra I, O'Neill AJ.
Intrinsic novobiocin resistance in Staphylococcus saprophyticus.
Antimicrob Agents Chemother. 2007 Sep 17; [Epub ahead of print].
Serichantalergs O, Jensen LB, Pitarangsi C, Mason CJ, Dalsgaard A.
A possible mechanism of macrolide resistance among multiple resistant
Campylobacter jejuni and Campylobacter coli isolated from Thai
children during 1991-2000. Southeast Asian J Trop Med Public
Health. 2007 May; 38(3):501-6.
Tellevik MG, Sollid JE, Blomberg B, Jureen R, Urassa WK, Langeland N.
Extended-spectrum beta-lactamase-type SHV-12-producing
Enterobacteriaceae causing septicemia in Tanzanian children: Vectors
for horizontal transfer of antimicrobial resistance. Diagn
Microbiol Infect Dis. 2007 Sep 17; [Epub ahead of print].
Peng CF, Lee MF, Fu HT, Chen YJ, Hsu HJ.
Characterization of class 1 integrons and antimicrobial resistance in
CTX-M-3-producing Serratia marcescens isolates from southern
Taiwan. Jpn J Infect Dis. 2007 Sep; 60(5):250-6.
Asai T, Harada K, Ishihara K, Kojima A, Sameshima T, Tamura Y,
Takahashi T.
Association of antimicrobial resistance in campylobacter isolated from
food-producing animals with antimicrobial use on farms. Jpn J
Infect Dis. 2007 Sep; 60(5):290-4.
Deep, Arora U.
Extended spectrum beta lactamase-mediated resistance among isolates of
family enterobacteriaceae. Indian J Pathol Microbiol. 2007 Apr;
50(2):458-61.
Chao G, Zhou X, Jiao X, Qian X, Xu L.
Prevalence and antimicrobial resistance of foodborne pathogens
isolated from food products in China. Foodborne Pathog Dis. 2007
Fall; 4(3) 277-84.
Hald T, Lo Fo Wong DM, Aarestrup FM.
The attribution of human infections with antimicrobial resistant
infections salmonella bacteria in Denmark to sources of animal origin.
Foodborne Pathog Dis. 2007 Fall; 4(3): 313-26.
Crivaro V, Bagattini M, Salza MF, Raimondi F, Rossano F, Triassi M,
Zarrilli R.
Risk factors for extended-spectrum beta-lactamase-producing
Serratia marcescens and Klebsiella pneomoniae acquisition
in a neonatal intensive care unit. J Hosp Infect. 2007 Sep 18; [Epub
ahead of print].
Boyce JM, Havill NL, Otter JA, Adams NMT.
Widespread environmental contamination associated with patients with
diarrhea and methicillin-resistant Staphylococcus aureus
colonization of the gastrointestinal tract. Infect Control Hosp
Epidemiol. 2007 Oct; 28(10): 1142-1147.
Chen KT, Campbell H, Borrell LN, Huard RC, Saiman LS, Della-Latta P.
Predictors and
outcomes for pregnant women with vaginal-rectal carriage of
community-associated methicillin-resistant Staphylococcus aureus.
Amer J Perinat. 2007; 24(4): 235-240.
Bischoff WE, Tucker BK, Wallis ML, Reboussin BA, Pfaller MA, Hayden FG,
Sherertz RJ.
Preventing the airborne spread of Staphylococcus aureus by
persons with the common cold: Effect of surgical scrubs, gowns, and
masks. Infect Control Hosp Epidemiol. 2007 Oct; 28(10): 1148-1154.
Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, Noskin GA,
Zembower T.
Screening for extended-spectrum beta-lactamase-producing
Enterobacteriaceae among high-risk patients and rates of subsequent
bacteremia. Clin Infect Dis. 2007 Oct 1; 45(7): 846-852.
Lowy FD, Aiello AE, Bhat M, Johnson-Lawrence VD, Lee M, Burrell E,
Wright LN, Vasquez G, Larson EL.
Staphylococcus aureus colonization and infection in New York
State prisons. J Infect Dis. 2007 Sept 15; 196(6): 911-918.
Rim JY, Bacon AE.
Prevalence of community-acquired methicillin-resistant
Staphylococcus aureus colonization in a random sample of healthy
individuals. Infect Control Hosp Epidemiol. 2007 Sept; 28(9):
1044-1046.
Anderson DJ, Sexton DJ, Kanafani ZA, Auten
G, Kay KS.
Severe surgical site infection in community hospitals: Epidemiology,
key procedures, and the changing prevalence of methicillin-resistant
Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007
Sept; 28(9): 1047-1053.
Jones JC, Rogers TJ, Brookmeyer P, Dunne
WM, Storch GA, Coopersmith CM, et al.
Mupirocin resistance in patients colonized with methicillin-resistant
Staphylococcus aureus in a surgical intensive care unit.
Clin Infect Dis. 2007 Sept 1; 45(5): 541-547.
Schneider-Lindner V, Delaney JA, Dial S, Dascal A, Suissa A.
Antimicrobial drugs and community-acquired methicillin-resistant
Staphylococcus aureus, United Kingdom. Emerg Infect Dis.
[serial on the Internet]. 2007 Jul. Available from
http://www.cdc.gov/EID/content/13/7/994.htm
Martineau AR, Newton SM, Wilkinson KA, Kampmann B, Hall BM, Nawroly N,
et al.
Neutrophil-mediated innate immune resistance to mycobacteria. J
Clin Invest. 2007 Jul 2; 117(7):1988-1994.
Chiang WC, Chen SY, Chien KL, Wu GH, Yen AM, Su CP, et al.
Predictive model of antimicrobial-resistant gram-negative bacteremia
at the ED. Am J Emerg Med. 2007 Jul; 25(6):597-607.
Tam VH, Louie A, Fritsche TR, Deziel M, Liu W, Brown DL, et al.
Impact of drug-exposure intensity and duration of therapy on the
emergence of Staphylococcus aureus resistance to a quinolone
antimicrobial. J Infect Dis. 2007 June 15; 195(12): 1818-27.
Scott P, Deye G, Srinivasa A, Murray C,
Moran K, Hulten E, et al.
An outbreak of multidrug-resistant Acinetobacter
baumannii-calcoaceticus complex infection in the US military
health care system associated with military operations in Iraq.
Clin Infect Dis. 2007 June 15; 44(12): 1577-84.
Knoll B, Tleyjeh IM, Steckelberg JM,
Wilson WR, Baddour LM.
Infective endocarditis due to penicillin-resistant viridans group
streptococci. Clin Infect Dis. 2007 June 15; 44(12): 1585-92.
Riedel S, Beekman SE, Heilmann KP, Richter SS, Garcia-de-Lomas J,
Ferech M, et al.
Antimicrobial use in Europe and antimicrobial resistance in
Streptococcus pnuemoniae. Eur J Clin Microbiol Infec Dis. 2007
Jun 6. [Epub ahead of print].
LaRosa LA, Fishman NO, Lautenbach E,
Koppel RJ, Morales KH, Linkin DR.
Evaluation of antimicrobial therapy orders circumventing an
antimicrobial stewardship program: Investigating the strategy of
"stealth dosing". Infect Control Hosp Epidemiol. 2007; 28:551-556.
Delaney JAC, Dial S, Barkun A, Suissa S.
Antimicrobial drugs and community-acquired Clostridium difficile–associated
disease, UK. Emerg Infect Dis [serial on the Internet]. 2007 May. Available from
http://www.cdc.gov/EID/content/13/5/761.htm
Schmidt C, Loffler B, Ackermann G.
Antimicrobial phenotypes and molecular basis in clinical strains of
Clostridium difficile. Diagn Microb Infect Dis. 2007 May 15 [epub
ahead of print].
Wei HL, Wang YW, Li CC, Tung SK, Chiou CS.
Epidemiology and evolution of genotype and antimicrobial resistance of
an imported Shigella sonnei clone circulating in central Taiwan.
Diagn Microbiol Infect Dis. 2007 May 15 [epub ahead of print].
Askarian M, Reza Moravveji A, Assadian O.
Prescription of prophylactic antibiotics for neurosurgical procedures
in teaching hospitals in Iran. Am J Infect Control. 2007 May;
35(4): 260-2.
Boczek LA, Rice EW, Johnston B, Johnson JR.
Occurrence of antibiotic resistant uropathogenic Escherichia coli
colonal group A in wastewater effluents. Appl Environ Microbiol.
2007 May 4; [Epub ahead of print].
Almeida FS, Nakano V, Avila-Campos MJ.
Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides
fragilis in calves and evaluation of their antimicrobial
susceptibility. FEMS Microbiol Lett. 2007 May 4; [Epub ahead of
print].
Ahmed NA, Petersen FC, Scheie AA.
AI-2 quorum sensing affects antibiotic susceptibility in
Streptococcus anginosus. J Antimicrob Chemother. 2007
May 9; [Epub ahead of print].
Landman D, Bratu S, Kochar S, Panwar M, Trehan M, Doymaz M, Quale J.
Evolution of antimicrobial resistance among Pseudomonas aeruginosa,
Acinetobacter baumannii, and Klebsiella pneumoniae in
Brooklyn, NY. J Antimcirob Chemother. 2007 May 9; [Epub ahead of
print].
Lee YJ, Kim HJ, Park CK, Kim KS, Bae DH, Kang MS, Cho JK, Kim AR, Kim
JW, Kim BH.
Characterization of Salmonella spp. isolated from an integrated
broiler chicken operation in Korea. J Vet Med Sci. 2007 Apr;
69(4):399-404.
McBryde
ES, Pettitt AN, McElwain DL.
A stochastic mathematical model of methicillin resistant
Staphylococcus aureus transmission in an intensive care unit:
Predicting the impact of interventions. J Theor Biol. 2007 Apr 7;
245(3):470-81 [Epub 2006 Nov 17].
Centers for Disease Control and
Prevention.
Severe methicillin-resistant Staphylococcus aureus
community-acquired pneumonia associated with influenza --- Louisiana
and Georgia, December 2006-January 2007. Morbidity and Mortality
Weekly Report. 2007 Apr 13; 56(14): 325-329.
Nguyen DM, Bancroft E, Mascola L, Guevara
R, Yasuda L.
Risk factors for neonatal methicillin-resistant Staphylococcus
aureus infection in a well-infant nursery. Infect Control Hosp
Epidemiol. 2007 Apr; 28(4):406-11.
Dorobat OM, Moisoiu A, Talapan D.
Incidence and resistance patterns of pathogens from lower respiratory
tract infections (LRTI). Pneumologia. 2007 Jan-Mar; 56(1): 7-15.
Pearson J, Turnidge J, Franklin C, Bell J,
Australian Group on Antimicrobial Resistance.
Prevalence of antimicrobial resistance in common pathogenic
Enterobacteriaceae in Australia, 2004: Report from the Australian
Group on Antimicrobial Resistance. 2007 Mar; 31(1): 106-12.
MacKenzie FM, Bruce J, Struelens MJ,
Goossens H, Mollison J, Gould IM, ARPAC Steering Group.
Antimicrobial drug use and infection control practices associated with
the prevalence of methicillin-resistant Staphylococcus aureus
in European hospitals. Clin Microbiol Infect. 2007 Mar;
13(3):269-276.
Mohapatra PR.
The threat of extensively drug-resistant tuberculosis. Clin Infect
Dis. 2007 Mar 15; 44:888-889.
Ruhe JJ, Smith N, Bradsher RW, Menon A.
Community-onset methicillin-resistant Staphylococcus aureus
skin and soft-tissue infections: Impact of antimicrobial therapy on
outcome. Clin Infect Dis. 2007 Mar 15; 44:777-784.
Taur T & Smith MA.
Adherence to the Infectious Diseases Society of America Guidelines in
the treatment of uncomplicated urinary tract infection. Clin
Infect Dis. 2007 Mar 15; 44:769-774.
Mackenzie FM, Bruce J, Struelens MJ,
Goossens H, Mollison J, Gould IM.
Antimicrobial drug use and infection control practices associated with
the prevalence of methicillin-resistant Staphylococcus aureus
in European hospitals. Clin Microbiol Infect. 2007 Mar; 13(3):
269-76.
Shah NS, Wright A, Bai G-H, Barrera L,
Boulahbal F, Martín-Casabona N, et al.
Worldwide emergence of extensively drug-resistant tuberculosis.
Emerg Infect Dis [serial on the Internet]. 2007 Mar. Available from
http://www.cdc.gov/EID/content/13/3/06-1400.htm
Lesens O, Haus-Cheymol R, Dubrous P,
Verret C, Spiegel A, Bonnet R, et al.
Methicillin-susceptible, doxycyline-resistant Staphylococcus
aureus, Côte d'Ivoire. Emerg Infect Dis [serial on the
Internet]. 2007 Mar. Available from
http://www.cdc.gov/EID/content/13/3/488.htm
Graber CJ, Wong MK, Carleton HA, Perdreau-Remington
F, Haller BL, Chambers HF.
Intermediate vancomycin susceptibility in a community-associated MRSA
clone. Emerg Infect Dis [serial on the Internet]. 2007 Mar.
Available from
http://www.cdc.gov/EID/content/13/3/491.htm
Kleiner DK, Katz SE, Ward PL.
Development of in vitro antimicrobial resistance in bacteria exposed
to residue level exposures in antimicrobial drugs, pesticides and
veterinary drugs. Chemoth. 2007;53:132-136.
Wang J-T, Fang C-T, Chen Y-C, Wu C-L, Chen
M-L, Chang S-C.
Staphylococcal cassette chromosome mec in MRSA, Taiwan.
Emerg Infect Dis [serial on the Internet]. 2007 Mar.
Available from http://www.cdc.gov/EID/content/13/3/494.htm
Polk RE, Fox C, Mahoney A, Letcavage J,
MacDougall C.
Measurement of adult antibacterial use in 130 US hospitals: Comparison
of defined daily dose and days of therapy. Clin Infect Dis. 2007
Mar 1; 44:664-670.
Larson EL, Quiros D, Giblin T, Lin S.
Relationship of antimicrobial control
policies and hospital and infection control characteristics to
antimicrobial resistance rates. Amer J Crit Care. 2007 Mar;
16(2):1-11.
O'neill AJ, McLaws F, Kahlmeter G,
Henriksen AS, Chopra I.
Genetic basis of resistance to fusidic acid in staphylococci.
Antimicrob Agents Chemother. 2007 Feb 26; [Epub ahead of print].
Brissette CA, Lukehart SA.
Mechanisms of decreased susceptibility to beta-defensins by
Treponema denticola. Infect Immun. 2007 Feb 26; [Epub ahead of
print].
Lee SY, Fan HW, Sutherland C, Deryke AC,
Nicolau DP.
Antibacterial effects of moxifloxacin and levofloxacin simulating
epithelial lining fluid concentrations against community-acquired
methicillin-resistant Staphylococcus aureus. Drugs R D.
2007; 8(2): 69-77.
Miller LG, Perdreau-Remingon F, Bayer AS,
Diep B, Tan N, Bharadwa K, Tsui J, Perlroth J, Shay A, Tagudar G,
Ibebuogu U, Spellberg B.
Clinical and epidemiologic characteristics cannot distinguish
community-associated methicillin-resistant Staphylococcus aureus
infection from methicillin-susceptible S. aureus infection: A
prospective investigation. Clin I | 